AADC Polynucleotides for the Treatment of Parkinson's Disease
Copyright © Targeted News Service, 2024
2024-05-07
Copyright © Targeted News Service, 2024
2024-05-07
ALEXANDRIA, Virginia, May 7 -- VOYAGER THERAPEUTICS, INC., Cambridge, Massachusetts has been assigned a patent (No. US 11975056 B2, initially filed May 3, 2021) developed by three inventors Robert Kotin, Boston, Massachusetts; Adrian Philip Kells, Arlington, Massachusetts; and Bernard Ravina, Cambridge, Massachusetts, for "AADC polynucleotides for the treatment of Parkinson's disease." . . .